Bokia Coretha Baguida

Factors Associated with Virological Failure under Dolutegravir-based Therapy in HIV-1 Infected Patients in the Central African Republic (2023–2025)

Laris Michael Dan-Houron Bejendo, Héritier Obed Lango, Clotaire Donatien Rafaï, Christelle Luce Bobossi, Serge Gbazi, Wanh-Ingo Hissein Hereidebona, Bokia Coretha Baguida, Moynam Heredeibona, Boniface Koffi & Ernest Lango-Yaya · Microbiology Research Journal International · 2026

Introduction: HIV‑1 remains a major public health issue, with a prevalence of 3.5% in the Central African Republic. Dolutegravir (DTG)-based regimens are recommended as first-line therapy due to their high efficacy and resistance barrier, yet virological failure persists, influen...